Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
Ayaka TanifujiSatoko OhfujiKosuke MatsumotoMasanori AbeAtsumasa KomoriAtsushi TakahashiKazuhito KawataKen SatoSatoru JoshitaTakeji UmemuraMasayuki UenoNobuaki NakayamaKeisuke KakisakaTeruko Arinaga-HinoKoichi ItoSachiko KanaiRyo MiuraToshihiko ArizumiYoshinari AsaokaTakanori ItoTetsuya ShimizuHiroshi YoshidaMasayuki OhtaSuguru MizunoHiroyuki IsayamaYouichi MorimotoSatoshi MochidaHiromasa OhiraAtsushi TanakaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)
SARS-CoV-2 vaccines demonstrated satisfactory safety and effectiveness in Japanese patients with intractable hepatobiliary diseases.